| # | Side effect | Count |
|---|---|---|
| 0 | OFF LABEL USE | 1227 |
| 1 | FEBRILE NEUTROPENIA | 853 |
| 2 | MUCOSAL INFLAMMATION | 830 |
| 3 | PRODUCT USE IN UNAPPROVED INDICATION | 601 |
| 4 | DRUG INEFFECTIVE | 558 |
| 5 | PYREXIA | 533 |
| 6 | CYTOMEGALOVIRUS INFECTION | 531 |
| 7 | ACUTE GRAFT VERSUS HOST DISEASE | 465 |
| 8 | ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 464 |
| 9 | CYTOMEGALOVIRUS INFECTION REACTIVATION | 454 |
| # | Side effect | Count | Frequency |
|---|---|---|---|
| 0 | PRE-ENGRAFTMENT IMMUNE REACTION | 47 | 0.5875 |
| 1 | AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME | 21 | 0.3559 |
| 2 | ADENOVIRUS REACTIVATION | 40 | 0.2778 |
| 3 | VIRAL HAEMORRHAGIC CYSTITIS | 149 | 0.2093 |
| 4 | DISSEMINATED TOXOPLASMOSIS | 24 | 0.2000 |
| 5 | ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE | 278 | 0.1967 |
| 6 | ENGRAFTMENT SYNDROME | 113 | 0.1912 |
| 7 | ACUTE GRAFT VERSUS HOST DISEASE IN SKIN | 464 | 0.1677 |
| 8 | HUMAN HERPESVIRUS 6 INFECTION | 305 | 0.1612 |
| 9 | GASTROENTERITIS ADENOVIRUS | 25 | 0.1592 |